MD, PhD Professor Translational Pediatric Oncology Pediatric Oncologist, and PI. Senior Consultant pediatric oncology and hematology Erasmus MC-Sophia Children’s Hospital 1997-2014. Working Group leader at the ‘Erasmus MC Postgraduate Molecular Medicine School’ which is recognized by the Dutch Royal Academy of Science and Arts, 2009-2015.

Previous chair of the international EWOG-MDS foundation (2007-2016). Chair of the national core group member Dutch Late effects group, and co-PI of the DCOG LATER study (2007-2020). One of the pioneers, since 2015, of the Princess Máxima Center for Pediatric Oncology, where she has established, apart from research regarding the identification of (genetic) determinants of direct and late childhood cancer related toxicity,  the national centralized care and translational research, Childhood Comprehensive Cancer program for all Dutch children with renal tumors. Leading the international SIOP-RTSG office trial management team (launched in >25 countries) for the UMBRELLA study, since 2018. Chair of the SIOP-RTSG (2022 onwards), and co-chair of the SIOP-RTSG & COG-RTG consortium (HARMONICA). Professor Translational Pediatric Oncology at the University of Utrecht since 2016. Group leader of a research group of 25 PhD & Post-docs, in the Princess Máxima Center for Pediatric Oncology in Utrecht, Supervisor of > 50 PhD projects (of which >30 already successfully defended). Dedicated to translational research in pediatric oncology, with a special focus on renal tumors and the (genetic) variation of early and late toxicity of childhood cancer.